Catalent Pharma Solutions Claimed Company

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com. read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 87

TOTAL RATINGS: 2479

CEO: Alessandro Maselli

Catalent Pharma Solutions Investor Relations Salaries in New York

The average Catalent Pharma Solutions Investor Relations in New York earns an estimated $57,545 annually. Catalent Pharma Solutions' Investor Relations compensation is $24,386 less than the US average for a Investor Relations.

In New York, The Communications Department at Catalent Pharma Solutions earns $36,624 more on average than the Enterprise Risk Department.

Last updated 2 months ago.

$35k

$47k

$63k

$70k

$109k

$139k

$168k

$57,545

Average Compensation

$57,545: avg. base

Investor Relations Salaries at Catalent Pharma Solutions

* estimated salary

Compensation at Catalent Pharma Solutions by Department

In New York, The Communications Department averages $36,624 more than the Enterprise Risk Department.

Communications

$207,701 Avg. total comp.

Enterprise Risk

$171,077 Avg. total comp.

-$37k

Product

$131,391 Avg. total comp.

-$76k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to Catalent Pharma Solutions reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at Catalent Pharma Solutions Rate Their Compensation

The majority of Investor Relations at Catalent Pharma Solutions believe they're compensated fairly. 100% of Investor Relations at Catalent Pharma Solutions say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Catalent Pharma Solutions

Do you believe you're paid fairly?

75% Yes

Does your company give annual bonuses?

100% Yes

100

Are you satisfied with your Benefits?

74% Yes

Rate your company